<DOC>
	<DOC>NCT00340704</DOC>
	<brief_summary>Aims of this study is to characterize the pharmacokinetic/pharmacodynamic profile and evaluate the safety, efficacy and tolerability, of tamsulosin hydrochloride as treatment in children with a neuropathic bladder, over the course of 12 months of active treatment.</brief_summary>
	<brief_title>PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Neurogenic</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Neuropathic bladder secondary to known neurological disorder Elevated detrusor leak point pressures (LPP) â‰¥40 cm H2O confirmed by two measurements at baseline Clinically significant abnormalities as determined by the investigator A history of relevant orthostatic hypotension, fainting spells or blackouts</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>tamsulosin</keyword>
	<keyword>pediatric</keyword>
	<keyword>neurogenic bladder</keyword>
</DOC>